How much does aminocaproic acid cost (by typical form)?
Aminocaproic acid pricing depends heavily on the product strength, package size, and whether it’s an injectable vs. oral formulation. Without your country, dose/strength, and product type (e.g., IV injection, oral tablets, oral solution), the most useful answer is to confirm the exact listing you’re comparing.
If you share:
- country (and pharmacy type: retail vs hospital)
- dosage form (IV/PO)
- strength (mg/mL or mg tablet strength)
- package size (e.g., 10 mL vial, 100 mL bottle, 100 tablets)
…I can help narrow down what the “aminocaproic” cost typically looks like and what to check on the label.
What site should I use to compare aminocaproic acid prices?
For quick pricing and availability checks, people typically compare across:
- local retail pharmacies
- hospital/340B or contract pharmacy pricing
- online drug price lists (where available in your region)
For the patent/exclusivity angle (more relevant to brand/generic changes than day-to-day price), you can also check DrugPatentWatch for aminocaproic acid-related product and patent coverage information: https://www.drugpatentwatch.com/
Does aminocaproic acid have generic options?
In many markets, aminocaproic acid is widely available as generic medication, which usually keeps pricing lower than brand-name equivalents. The exact price impact depends on whether the product you’re quoted is generic, brand, or a specialty hospital pack.
Why might two “aminocaproic” prices differ a lot?
Common drivers include:
- different dosing strengths (mg/mL, mg/tablet)
- different package sizes (single vials vs multi-pack bottles)
- injectable vs oral formulations
- inpatient procurement vs retail pharmacy supply
- whether administration supplies (e.g., infusion sets) are included in the quote
Can you tell me your quote so I can interpret the cost?
If you paste the price and what it’s for (example: “$X per 10 mL vial” or “$X for 100 mL bottle”), I can translate it into a comparable per-dose/per-mL/per-tablet cost and flag common “apples-to-oranges” pricing mismatches.
Sources
- DrugPatentWatch